Occlusive devices

• US 10,478,194 B2
• Filed: 09/23/2015
• Issued: 11/19/2019
• Est. Priority Date: 09/23/2015
• Status: Active Grant

• Current Assignee: Covidien LP (Medtronic Plc)
• Original Assignee: Covidien LP (Medtronic Plc)
• Inventors: Rhee, Richard, Bardsley, Earl
• Primary Examiner(s): Tanner, Jocelin C
• Application Number:
  US14/862,522
• Publication Number:
  US 20170079662A1
• Time in Patent Office: 1,518 Days
• CPC Class Codes: A61B 17/12031 complete occlusion
• CPC Class Codes: A61B 17/12113 within an aneurysm
• CPC Class Codes: A61B 17/12172 having a pre-set deployed three-dimensional shape methods of manufacturing A61B2017/00526
• CPC Class Codes: A61B 17/12177 comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
• CPC Class Codes: A61B 17/12186 liquid materials adapted to be injected
• CPC Class Codes: A61B 2017/00526 Methods of manufacturing

Abstract

An implant can include a frame and a mesh component coupled to the frame. The mesh component can define a first porosity, and the frame can define a frame porosity. The combined porosity of the mesh component and the frame can restrict blood flow into the implant.

Claims

1. An implant for occluding a target area of a patient'"'"'s vasculature, comprising:

a frame comprising a lattice formed of a first plurality of braided filaments that define a first plurality of openings, the first openings having a pore size of from about 1 μ

m to about 400 μ

m, the frame comprising a distal region and a proximal region, the frame being expandable from a compressed configuration to an expanded configuration in which the frame has a generally spherical shape, and wherein the first plurality of filaments are coupled together at a hub disposed at a proximal end of the frame;

a first mesh component coupled to the frame along at least a first portion of the proximal region, the first mesh component comprising a second plurality of braided filaments that define a second plurality of openings, the second pluralities of filaments and openings collectively defining a mesh porosity permitting blood flow therethrough, the mesh porosity being less than a porosity of the frame, such that blood flow into the implant is more restricted along the proximal region than along the distal region of the frame; and

a second mesh component coupled to the frame along at least a second portion of the proximal region, the second portion differing from the first portion, the second mesh component comprising a third plurality of braided filaments that define a third plurality of openings,

wherein a proximal end of the implant is configured to be detachably coupled to a delivery device.

2. The implant of claim 1, wherein the mesh porosity is a first mesh porosity, and the second mesh component comprises a second mesh porosity different from the first porosity.

3. The implant of claim 1, wherein first and second mesh components overlie adjacent first openings in the frame.

4. The implant of claim 1, further comprising a third mesh component coupled to the frame along the proximal region.

5. The implant of claim 4, wherein the mesh porosity is a first mesh porosity, and wherein the third mesh component comprises a third mesh porosity, different from the first mesh porosity.

6. The implant of claim 4, wherein the mesh porosity is a first mesh porosity, and wherein the second mesh component comprises a second mesh porosity, and the third mesh component comprises a third mesh porosity, different from the second mesh porosity.

7. The implant of claim 4, wherein the first, second, and third mesh components abut one another along a surface of the frame.

8. The implant of claim 1, wherein the first mesh component is fixedly coupled to the frame at a plurality of coupling points.

9. The implant of claim 8, wherein the first mesh component is welded to the frame at the plurality of coupling points.

10. The implant of claim 1, wherein an end of the first mesh component abuts an end of the second mesh component along a surface of the frame.

11. The implant of claim 1, wherein the first and second mesh components are coupled to the frame such that an end portion of the first mesh component adjoins or abuts an end portion of the second mesh component.

12. The implant of claim 1, wherein an individual one of the first plurality of braided filaments is between at least a portion of the first and second mesh components.

13. An implant for occluding a target area of a patient'"'"'s vasculature, comprising:

a lattice formed of a braided frame comprising first filaments that intersect each other to define first openings having a pore size of from about 1 μ

m to about 400 μ

m, the frame being expandable from a compressed configuration to an expanded configuration in which the frame has a generally spherical shape, wherein the first filaments are coupled together at a hub disposed at a proximal end of the frame,

a first mesh component coupled to the frame, the first mesh component comprising second filaments and second openings that collectively define a mesh porosity permitting blood flow therethrough, wherein the mesh porosity is less than a porosity of the frame for restricting blood flow into the implant; and

a second mesh component coupled to the frame, the second mesh component comprising a third plurality of braided filaments that define a third plurality of openings,

wherein an individual one of the first filaments is between the first and second mesh components, and

wherein a proximal end of the implant is configured to be detachably coupled to a delivery device.

14. The implant of claim 13, wherein the mesh porosity is a first mesh porosity, and wherein the second mesh component comprises a second mesh porosity, different from the first mesh porosity.

15. The implant of claim 13, wherein the second mesh component is positioned adjacent to the first mesh component.

16. The implant of claim 13, further comprising a third mesh component coupled to the frame along a proximal region thereof.

17. The implant of claim 16, wherein the first, second, and third mesh components abut one another along a surface of the frame.

18. The implant of claim 13, wherein the first mesh component surrounds substantially all of the frame.

19. The implant of claim 13, wherein an end of first mesh component abuts an end of the second mesh component along a surface of the frame.

20. An implant for occluding a target area of a patient'"'"'s vasculature, comprising:

a frame comprising a proximal region and first filaments that intersect each other to define first openings having a pore size of from about 1 μ

m to about 400 μ

m, the frame being expandable from a compressed configuration wherein the first filaments are coupled together at a hub disposed at a proximal end of the frame to an expanded configuration; and

a first mesh component coupled to a first portion of the proximal region of the frame, the first mesh component comprising second filaments and a first mesh porosity configured to permit blood flow therethrough, wherein the first mesh porosity is less than a porosity of the frame; and

a second mesh component coupled to a second portion of the proximal region of the frame, the second portion differing from the first portion, the second mesh component comprising third filaments and a second mesh porosity configured to permit blood flow therethrough, the second mesh porosity differing from the first mesh porosity,

wherein a proximal end of the implant is configured to be detachably coupled to a delivery device.